Along these lines, we observed a negative correlation between HB-EGF levels in the CSF and the number of CNS lesions in CIS patients, which has been described as an important risk factor for the conversion to RRMS16 (Fig. 1g). Here, HBEGF is linked to in situ carcinoma.